Type 1 Diabetes: Study of NNC0363-1063

We are researching a new medicine to see how it affects healthy participants and those with type 1 diabetes. This study aims to gather information that could improve diabetes treatment.

1-2 yearsSafety phase (I)DiabetologyEndocrinology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
PROFIL Institut fuer Stoffwechselforschung GmbH
Neuss, Germany
Sponsor: Novo Nordisk A/S
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.